Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXL2E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,477
Award facts
- Contract value 100% obligated
- $11,477.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 30, 2026, for Zepbound 10 mg/0.5 ml pen injections valued at $11,477.28. This firm fixed-price, competitively awarded contract carries an ultimate completion date of February 2, 2026, with performance occurring at the awardee's Conshohocken facility. The award is not set-aside and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle through December 2031 that serves as the primary procurement mechanism for pharmaceutical and medical supplies supporting military healthcare programs globally.
This delivery order for the Eli Lilly obesity and diabetes medication Zepbound reflects the ongoing pharmaceutical supply needs of the Defense Health Agency and other federal military healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a preferred vendor in the federal medical supply chain, with consistent awards across multiple therapeutic domains including specialty medications, vaccines, and medical devices. The award underscores the company's capability to meet competitive federal procurement requirements for time-sensitive medical commodity deliveries to support military treatment facilities and defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FXL2E?
SPE2DR26FXL2E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FXL2E worth?
The government has obligated $11,477 on SPE2DR26FXL2E.
Is contract SPE2DR26FXL2E an order under another contract?
Yes. SPE2DR26FXL2E is a delivery order under SPE2DR25D6037, an indefinite delivery contract.
Was contract SPE2DR26FXL2E competed?
The extent of competition for SPE2DR26FXL2E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award